|
MAP's Levadex Ready For FDA Approval
|
|
Mannkind
|
Feb 03, 2013 09:01AM
|
|
Key IT Decision Makers at Mannkind
|
|
Mannkind
|
Feb 02, 2013 08:54PM
|
|
Hiring:
|
|
Mannkind
|
Feb 02, 2013 10:07AM
|
|
Pediatric type 2 diabetes guidelines stress metformin
|
1
|
Mannkind
|
Feb 01, 2013 04:16PM
|
|
Re: Volume surge
|
|
Mannkind
|
Feb 01, 2013 01:34PM
|
|
100% Upside on these Bio-techs
|
|
Mannkind
|
Jan 31, 2013 12:49PM
|
|
Generex: Research For Sale On The Cheap
|
|
Mannkind
|
Jan 31, 2013 10:34AM
|
|
Re: Diabetes Forecast Magazine Poll
|
|
Mannkind
|
Jan 30, 2013 01:36PM
|
|
Keryx Defies Gravity
|
|
Mannkind
|
Jan 30, 2013 11:55AM
|
|
2 Things to Watch at MannKind Corporation
|
|
Mannkind
|
Jan 29, 2013 09:56AM
|
|
Afrezza Inhaled Insulin for Diabetes Mellitus
|
3
|
Mannkind
|
Jan 28, 2013 04:50PM
|
|
A Biopharmaceutical Lottery Ticket
|
4
|
Mannkind
|
Jan 20, 2013 05:30PM
|
|
Re: U.S. Patents Awarded to Inventors in California (Jan. 19)
|
2
|
Mannkind
|
Jan 20, 2013 08:44AM
|
|
U.S. Patents Awarded to Inventors in California (Jan. 19)
|
|
Mannkind
|
Jan 19, 2013 05:00PM
|
|
Re: Updated Share Price Model
|
|
Mannkind
|
Jan 18, 2013 06:59PM
|
|
Re: Updated Share Price Model
|
|
Mannkind
|
Jan 18, 2013 06:41PM
|
|
Re: Updated Share Price Model
|
|
Mannkind
|
Jan 18, 2013 06:31PM
|
|
Re: Updated Share Price Model
|
1
|
Mannkind
|
Jan 18, 2013 02:29PM
|
|
Re: Updated Share Price Model
|
|
Mannkind
|
Jan 18, 2013 11:49AM
|
|
Re: Updated Share Price Model
|
|
Mannkind
|
Jan 17, 2013 09:57PM
|
